semaglutide injection vs tirzepatide injection Maintenance therapy on or Tirzepatide vs Semaglutide: Temecula Medical

The FDA has approved Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, when used with a reduced-calorie diet and increased physical activity

Rather than guessing at meal plans or scrolling through generic advice online, patients work with a dietitian who understands the specific nutritional demands of GLP-1 therapy

Can semaglutide help fatigue

Blood Sugar Control Helps regulate insulin and glucose levels

Another concern involves medication adherence

Once-Weekly Injection Get to know Wegovy pen Weight Loss in Michigan Wegovy comes in a prefilled pen and is used once a week